• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • 中文 (中国)
  • English
Worcester HIV Vaccine

Worcester HIV Vaccine

  • Home
  • Our Science
    • PDPHV candidate
    • Vaccine approach
    • Our Clinical Trials
    • Preclinical studies
    • Publications
  • About WHV
    • Our Mission
    • Our History
    • Our Team
    • Our Advisors
    • Safety Monitoring Board
  • News
  • Contact us

HVTN 124 trial successfully passes first safety review

October 19, 2018

The HVTN 124 Protocol Safety Review Team has reviewed the cumulative safety data for the first 12 participants in Part A, and concluded that enrollment can begin in HVTN 124 Part B.

Learn more about the HVTN 124 trial

Filed Under: News

Footer

© 2019 Worcester HIV Vaccine

WHV Logo